Compared with Nov 1, 2026
Rolling edition · updates with the daily pipeline
PEPTIDEBENCHMARK MARKET INTELLIGENCE
November 2026
Peptide Price Index
Data through Nov 8, 2026INDEX VALUE115.15-3.8% 28 days
Baseline = 100 on Jun 3, 2026
Compared with Oct 11, 2026
Current lanes with at least three vendors
3,080 vendor observations
MARKET BREADTH
Most tracked medians moved lower
Movement is based on each peptide’s median effective price per milligram, with ±0.5% treated as approximately flat.
45down
26flat
7up
28-DAY MOVERS
The largest changes in median effective $/mg
These are market-lane medians—not a single vendor’s promotion or a claim about completed transactions.
Largest decreases
01Vilon9 vendors · $2.11/mg-14.7%02Glutathione78 vendors · $0.0456/mg-8.8%035-Amino-1MQ68 vendors · $2.00/mg-8.8%04Selank102 vendors · $4.00/mg-8.6%05SS-3166 vendors · $3.60/mg-8.2%06AHK-CU26 vendors · $0.4499/mg-7.5%07FOXO4-DRI24 vendors · $11.25/mg-7.4%08Thymalin13 vendors · $4.66/mg-7.0%Largest increases
01Hexarelin18 vendors · $9.00/mg+12.5%02TB-500 Fragment 17-237 vendors · $4.72/mg+7.1%03hGH Frag 176-1916 vendors · $6.16/mg+2.7%04MGF6 vendors · $13.35/mg+1.1%05Cardiogen13 vendors · $2.75/mg+0.9%06Mazdutide11 vendors · $8.96/mg+0.5%07Oxytocin43 vendors · $5.78/mg+0.5%08Survodutide16 vendors · $8.55/mg+0.3%NEW OBSERVED LOWS
Median prices at a new tracked low
Requires at least 14 qualifying observations and three current vendors. Gaps are not interpolated.
MARKET DEPTH
The most broadly priced peptide lanes
Vendor and offer counts help readers distinguish broad market signals from thinner listings.
| Peptide | Vendors | Offers | Median effective / mg | Current low / mg | 28 day |
|---|---|---|---|---|---|
| BPC-157 ↗ | 127 | 250 | $4.80 | $0.7470 | -2.0% |
| GHK-Cu ↗ | 123 | 257 | $0.5760 | $0.1375 | -4.0% |
| MOTS-c ↗ | 122 | 280 | $3.50 | $0.7470 | -7.0% |
| Tesamorelin ↗ | 108 | 202 | $6.30 | $2.03 | -2.8% |
| Ipamorelin ↗ | 108 | 155 | $5.22 | $0.7920 | -2.9% |
| NAD+ ↗ | 106 | 210 | $0.1020 | $0.0325 | -5.6% |
| Semax ↗ | 105 | 148 | $3.96 | $0.2400 | -0.5% |
| KPV ↗ | 105 | 132 | $4.27 | $0.7470 | -3.9% |
| Selank ↗ | 102 | 136 | $4.00 | $0.8190 | -8.6% |
| PT-141 ↗ | 100 | 121 | $4.00 | $0.7470 | -0.0% |
| DSIP ↗ | 99 | 137 | $5.33 | $0.8640 | -1.2% |
| TB-500 ↗ | 97 | 159 | $6.20 | $1.71 | -0.6% |
METHODOLOGY & CITATION
What this report measures—and what it does not
Every edition carries its construction and coverage snapshot so later citations are interpreted against the data available at publication.
Tracked listing prices
Median effective USD per milligram across exact-comparability offers, using the discount rules recorded with each pricing snapshot.
Fixed-cohort index
Equal-weighted fixed cohort. Each eligible peptide is normalized to 100 at its first observation; daily index values average available normalized medians and require at least 70% cohort coverage.
Coverage limits
This is a tracked-listing index, not a transaction-price index. Vendor mix, availability, quantities, discounts, and catalog coverage can change over time.
SUGGESTED CITATION
PeptideBenchmark. “November 2026 Peptide Price Index Report.” Data through Nov 8, 2026. https://peptidebenchmark.com/prices/reports/2026-11/